An analysis of FDA-approved drugs for infectious disease: Antibacterial agents

Drug Discovery Today

Volumn 19, Issue 9, 2014, Pages 1283-1287

  Kinch, Michael S ^a   Patridge, Eric ^a   Plummer, Mark ^a   Hoyer, Denton ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BIOTECHNOLOGY; DRUG APPROVAL; DRUG INDICATION; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; HUMAN; INFECTION; REVIEW; BACTERIAL INFECTIONS; DRUG DESIGN; UNITED STATES;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DRUG APPROVAL; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84907815937     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.07.005     Document Type: Short Survey

References (12)

1. D.S. Jones The burden of disease and the changing task of medicine N. Engl. J. Med. 366 2012 2333 2338
2. M.A. Schnitker Sulfanilamide: a review N. Engl. J. Med. 218 1938 503 511
3. C. Ballentine Taste of raspberries, taste of death: the 1937 elixir sulfanilamide incident FDA Consum. Mag. June 1981 15
4. M.S. Kinch, and E. Patridge An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs Drug Discov Today 2014 (in press)
5. I. Solomons Antibiotics in animal feeds: human and animal safety issues J. Anim. Sci. 46 1978 1360 1368
6. D.M. Shlaes Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals Clin. Infect. Dis. 25 1997 584 599
7. V.M. D'Costa Sampling the antibiotic resistome Science 311 2006 374 377
8. Infectious Diseases Society of America Combating antimicrobial resistance: policy recommendations to save lives Clin. Infect. Dis. 52 2011 S397 S428
9. B. Spellberg The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America Clin. Infect. Dis. 46 2008 155 164
10. K. Lewis Platforms for antibiotic discovery Nat. Rev. Drug Discov. 12 2013 371 387
11. D.A. Sclar Fidaxomicin for Clostridium difficile-associated diarrhoea Clin. Drug Invest. 32 2012 e17 e24
12. S. Laohavaleeson Effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infections Pharmacotherapy 28 2008 1471 1482.